AbbVie Inc (ABBV)
87.97
-0.03 -0.03%
NYSE
Jan 21, 16:58
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 32.87B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 2.165 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 3.255B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 77.36% |
| Profit Margin (Quarterly) | 22.22% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 4.99% |
| Price and Valuation | |
| Market Cap | 130.09B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 3.982 |
| PE Ratio | 40.63 |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -4.668 |
| Free Cash Flow (Quarterly) | 4.401B |
| Return on Equity | Upgrade |
View All ABBV News
News
-
WireHeadlineTime (ET)
-
Yahoo01/20 10:01
-
Yahoo01/20 09:18
-
Yahoo01/18 12:05
-
Yahoo01/18 09:51
-
Yahoo01/18 09:00
-
Yahoo01/17 09:32
-
Yahoo01/17 09:26
-
Yahoo01/17 08:11
-
Yahoo01/17 08:05
-
Yahoo01/16 11:31
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 04/24/2020 09:00 EDT | Misc | AbbVie Inc First Quarter Earnings Conference Call in 2020 |
| 04/24/2020 | Earnings | AbbVie Inc First Quarter Earnings in 2020 Release |
| 02/07/2020 08:00 CST | Misc | AbbVie Inc Fourth Quarter Earnings Conference Call for 2019 |
| 02/07/2020 | Earnings | AbbVie Inc Fourth Quarter Earnings in 2019 Release |
| 01/14/2020 | Dividends | Amount: 1.18, Declared Date: Nov 01 2019, Pay Date: Feb 14 2020 |
| 11/01/2019 | Earnings | AbbVie Inc Third Quarter Earnings for 2019 Release |
| 11/01/2019 09:00 EDT | Misc | AbbVie Inc Third Quarter Earnings Conference Call for 2019 |
| 10/11/2019 | Dividends | Amount: 1.07, Declared Date: Sep 10 2019, Pay Date: Nov 15 2019 |
| 07/26/2019 09:00 EDT | Misc | AbbVie Inc Second Quarter Earnings Conference Call in 2019 |
| 07/26/2019 | Earnings | AbbVie Inc Second Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.abbvieinvestor.com
- Investor Relations URL: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-IRHome
- HQ State/Province: Illinois
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Equity Style: Large Cap/Value
- Next Earnings Release: Feb. 07, 2020
- Last Earnings Release: Nov. 01, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Jan. 14, 2020
- Description: AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. The recent announced acquisition of Allergan will add several new drugs in aesthetics and women's health.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 87.97 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| XLV | Health Care Select Sector SPDR® ETF | 3.34% |
| VHT | Vanguard Health Care ETF | 2.91% |
| SDY | SPDR® S&P Dividend ETF | 2.33% |
| RCEEX | American Funds Capital Income Bldr R2E | 2.33% |
| RIBEX | American Funds Invmt Co of Amer R2E | 2.06% |
| NOBL | ProShares S&P 500 Dividend Aristocrats | 1.92% |
| RMEBX | American Funds American Mutual R2E | 1.63% |
| VYM | Vanguard High Dividend Yield ETF | 1.21% |
| IWF | iShares Russell 1000 Growth ETF | 0.81% |
| RWIEX | American Funds Capital World Gr&Inc R4 | 0.81% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABBV Tweets Stocktwits
Advertisement
